Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
City of Hope Medical Center
Incyte Corporation
Incyte Corporation
Palleon Pharmaceuticals, Inc.
Incyte Corporation
Institut Bergonié
NGM Biopharmaceuticals, Inc
Elevation Oncology
UNC Lineberger Comprehensive Cancer Center
Stanford University
Pfizer
Pfizer
ADC Therapeutics S.A.
Exelixis
Sumitomo Pharma America, Inc.
Pfizer
Pfizer
Hoffmann-La Roche
pharmaand GmbH
M.D. Anderson Cancer Center
OncoNano Medicine, Inc.
Revolution Medicines, Inc.
Herlev Hospital
Ludwig Institute for Cancer Research
Ludwig Institute for Cancer Research
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Duke University
Hoosier Cancer Research Network
Masonic Cancer Center, University of Minnesota
Five Prime Therapeutics, Inc.
Incyte Corporation
Seagen Inc.
Seagen Inc.
Seagen Inc.
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
Amgen
Amgen
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Barbara Ann Karmanos Cancer Institute
Sandoz
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Valerio Therapeutics